Advanced clinical bioanalysis services for all phases of drug development

Clinical Bioanalysis

Our integrated bioanalytical services support clients from nonclinical and all phases of clinical trials, ensuring precise and efficient analysis throughout product development. We utilize the latest technology for analyzing small and large molecules by following strict quality assurance measures.

From method development and validation to clinical analysis and support services, we offer advanced technologies, regulatory knowledge, and a deep understanding of the entire drug development process, trends, and advancements.

With our efficient logistics, sample management and advanced analytical techniques in place, we ensure on time delivery in full (OTIF), accuracy of data, and reduced cost of your clinical development programs.

One Stop Solutions for Regulatory Bioanalysis

Research Product concept & designDevelopment Candidate selectionNonclinical Efficacy PK/PD (Biomarker) GLP Safety Tox (TK & ADA)Phase I Safety PK (PD)Phase II Dose/Regime (Safety)Phase III Efficacy (Safety)MarketingApplicationPhase IV Label expansionPost Approval changesNew Indication Manufacture Safety updatesTherapeutic Drug MonitoringPre-BLA meetingSynthesis / ADME / Formulation / Method Development Non-GLPPK/PD & Immunogenicity Clinical BioanalysisPre - IND meetingAgreement on clinical plan using Tox dataMethod Transfer and validation for Regulatory BioanalysisInitial INDAdditional mammalian Reproductive & Chronic ToxicityAnimal POCHuman POCCommercialization
Research Product concept & designDevelopment Candidate selectionNonclinical Efficacy PK/PD (Biomarker) GLP Safety Tox (TK & ADA)Animal POCPhase I Safety PK (PD)Phase II Dose/Regime (Safety)Phase III Efficacy (Safety)Human POCMarketingApplicationPhase IV Label expansionPost Approval changesNew Indication Manufacture Safety updatesCommercializationTherapeutic Drug MonitoringPre-BLA meetingPK/PD & Immunogenicity Clinical BioanalysisSynthesis / ADME / Formulation / Method Development Non-GLPPre - IND meetingAgreement on clinical plan using Tox dataMethod Transfer and validation for Regulatory BioanalysisInitial INDAdditional mammalian Reproductive & Chronic Toxicity

Effective Transition from Preclinical to Clinical: Saving Costs, Time, and Resource

Service Portfolio

Method development Validation & Sample analysis as per Relevant Regulatory Guidelines

Pharmacokinetics

  • Quantitation of therapeutics using LC-MS/MS, Ligand Binding Assays - ELISA/ ECL methods

Immunogenicity (Screening, Confirmatory, Titers, Nab titers)

  • Quantitative immunoassays using ELISA/ ECL (MSD)
  • Cell based Neutralization assays
  • Quantification of Nabs by flow cytometry

Biomarkers Analysis

  • Detection of Cytokines and inflammatory biomarkers by Flow cytometry / ELISA
  • Detection of Biomarkers by ECL (MSD)/ ELISA/ LC-MS/MS.

 

Therapeutic Drug monitoring

  • Quantify drug and ADA levels in patients using above techniques

 

Bioanalytical Sample Management & Logistics

  1. Shipment

    • Sample shipment through global courier services
  2. Storage

    • Dedicated custodians to receive and handle samples
    • In-house sample tracking systems
  3. Archiving

    • Dedicated archivist and freezers for archiving of Samples

Equipments

Multiplate Readers - Agilent
Multiplate Readers - Agilent
MSD - Qickplex SQ120
MSD - Qickplex SQ120
SCIEX Triple Quad 4500
SCIEX Triple Quad 4500
Agilent UHPLC systems
Agilent UHPLC systems
BD FACSVerse flow cytometer
BD FACSVerse flow cytometer
QuantStudioTM RT-PCR
QuantStudioTM RT-PCR
Automated Washers
Automated Washers
Heidolph Plate incubator shake
Heidolph Plate incubator shake

State-of-art validated Instruments for high precision sample analysis

Discover our full range of services

Let's start your journey to safer solutions

Get In Touch Banner